1. Johnson RW, Gass JD. Idiopathic macular hole. Observations, stages of formation, and implications for surgical intervention. Ophthalmology. 1988; 95:917–24.
2. Yoon HS, Brooks HL, Capone A, et al. Ultrastructural features of tissue removed during idiopathic macular hole surgery. Am J Ophthalmol. 1996; 122:67–75.
Article
3. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Result of a pilot study. Arch Ophathalmol. 1991; 109:654–9.
4. Wendel RT, Patel AC, Kelly NE, et al. Vitreous surgery for macular holes. Ophthalmology. 1993; 100:1671–6.
Article
5. Thompson JT, Glaser BM, Sjaarda RN, et al. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2. Ophthalmology. 1994; 101:1195–200.
Article
6. Glaser BM, Michels RG, Kuppermann BD, et al. Transforming growth factor-beta2 for the treatment of full-thickness macular holes. A prospective randomized study. Ophthalmology. 1992; 99:1162–73.
7. Liggett PE, Skolik SA, Horrio B, et al. Human autologous serum for the treatment of full-thickness macular holes. Ophthalmology. 1995; 102:1071–6.
Article
8. Gauric A, Massin P, paques M. Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophathalmol. 1995; 233:549–54.
9. Brooks HL Jr. Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology. 2000; 107:1939–48.
Article
10. Kadonosono K, Itoh N, Uchio E, et al. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol. 2000; 118:1116–8.
Article
11. Gandorfer A, Messmer EM, Ulbig MW, Kampik A. Indocyanine green selectively stains the internal limiting membrane. Am J Ophthalmol. 2001; 131:387–8.
Article
12. Schmidt JC, Meyer CH, Rodrigues EB, et al. Staining of internal limiting membrane in vitreomacular surgery: a simplified technique. Retina. 2003; 23:263–4.
Article
13. Li K, Wong D, Hiscott P, et al. Trypan blue staining of internal limiting membrane and epiretinal membrane during vitrectomy: visual results and histopathological findings. Br J Ophthalmol. 2003; 87:216–9.
Article
14. Horio N, Horiguchi M, Yamamoto N. Triamcinolone-assisted internal limiting membrane peeling during idiopathic macular hole surgery. Arch Ophthalmol. 2005; 123:96–9.
Article
15. Brooks HL. Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology. 2000; 107:1939–48.
Article
16. Mester V, Kuhn F. Internal limiting membrane removal in the management of full thickness macular holes. Am J Ophthalmol. 2000; 129:769–77.
17. Park DW, Sipperley JO, Sneed SR, et al. Macular hole surgery with internal limiting membrane peeling and intravitreous air. Ophthalmology. 1999; 106:1392–7.
18. Krohn J. Duration of face-down positioning after macular hole surgery: a comparison between 1 week and 3 days. Acta Ophthalmol Scand. 2005; 83:289–92.
19. Sato H, Kawasaki R, Yamashita H. Observation of idiopathic full thickness macular hole closure in early postoperative period as evaluated by optical coherence tomography. Am J Ophthalmol. 2003; 136:185–7.
20. Doh SH, Kim KS, Kim KB, Yoo JS. Comparison of surgical results for idiopathic macular hole: Fluid-gas exchange vs. fluid-air exchange. J Korean Ophthalmol Soc. 2004; 45:451–6.
21. Isomae T, Sato Y, Shimada H. Shortening the duration of prone positioning after macular hole surgery – comparison between 1 week and 1 day prone positioning. Jpn J Ophthalmol. 2002; 46:84–8.
22. Sato Y, Isomae T. Macular hole surgery with internal limiting membrane removal, air tamponade, and 1-day prone positioning. Jpn J Ophthalmol. 2003; 47:503–6.
Article
23. Song BY, Ahn KY, Seo MS. Internal limiting membrane peeling using indocyanine green in vitrectomy for idiopathic macular hole. J Korean Ophthalmol Soc. 2004; 45:444–50.
24. Da Mata AP, Burk SE, Foster RE, et al. Long term follow-up of indocycnine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for idiopathic macular hole repair. Ophthalmology. 2004; 111:2246–53.
25. Lee JE, Oum BS. Macular hole surgery with or without indocyanine green assisted internal limiting membrane peeling. J Korean Ophthalmol Soc. 2003; 44:2553–9.
26. Kwok AK, Lai TY, Man-chan W, Woo DC. Indocyanine green assisted retinalinternal limiting membrane removal in stage 3 or 4 macular hole surgery. Br J Ophthalmol. 2003; 87:71–4.
27. Smiddy WE, Feuer W, Cordahi G. Internal limiting membrane peeling in macular hole surgery. Ophthalmology. 2001; 108:1471–8.
Article
28. Engelbrecht NE, Freeman J, Sternberg Jr P, et al. Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol. 2002; 133:89–94.
Article
29. Gale JS, Proulx AA, Gonder JR, et al. Comparison of the in vitro toxicity ofgreen to that of trypan blue in human retinal pigment epithelium cell cultures. Am J Ophthalmol. 2004; 138:64–9.